KORU Medical Systems Inc. Common Stock (DE) (KRMD)

FairStock Score: 45/100 — MIXED

Key Financials

Strengths

• Generates $874,285 in annual free cash flow (0.5% yield on market cap)
• Conservative balance sheet with debt-to-equity of just 0.20, providing financial flexibility
• Altman Z-Score of 9.3 confirms minimal bankruptcy risk and strong solvency
• Revenue growth of 23.3% demonstrates strong top-line momentum

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration

AI Analysis

KORU Medical Systems Inc. Common Stock (DE) is a micro-cap healthcare company valued at $187 million. Revenue stands at $43 million, though the company is currently unprofitable. From a quality standpoint, KORU shows solid Piotroski F-Score of 6/9 and Altman Z-Score of 9.3 confirms fortress-level solvency. On valuation, the stock is 0.4% FCF yield. Growth dynamics show revenue growing at 23.3% and profit growth of 68.8%. Our composite FairStock Score of 45/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

KORU's 23% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $874,285 in annual free cash flow (0.5% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer